Sentinel lymph node sampling in gynaecological cancers: Techniques and clinical applications

European Journal of Surgical Oncology

Volumn 35, Issue 7, 2009, Pages 675-685

  El Ghobashy, A E ^a   Saidi, S A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Gynaecology; Lymph node; Sentinel; Techniques

Indexed keywords

RADIOISOTOPE;

CANCER DIAGNOSIS; CLINICAL EVALUATION; CLINICAL STUDY; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HUMAN; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPH VESSEL; MELANOMA; MESH HEADING; MORBIDITY; OVARY CANCER; OVARY TUMOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVIX CANCER; VULVA CANCER;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 67349099147     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.09.004     Document Type: Review

References (86)

1. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
2. Glass L.F., Messina J.L., Cruse W., et al. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg 22 (1996) 715-720
3. Krag D.N., Meijer S.J., Weaver D.L., et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 130 (1995) 654-658 discussion 659-60
4. Mosca P.J., Tyler D.S., and Seigler H.F. Surgical management of cutaneous melanoma: current practice and impact on prognosis. Adv Surg 38 (2004) 85-119
5. Gipponi M., Bassetti C., Canavese G., et al. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. J Surg Oncol 85 (2004) 102-111
6. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
7. Wong J.H., Cagle L.A., and Morton D.L. Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214 (1991) 637-641
8. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
9. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398 discussion 398-401
10. Coleman R.L., Whitten C.W., O'Boyle J., et al. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure. J Surg Oncol 70 (1999) 126-129
11. Leong S.P., Donegan E., Heffernon W., et al. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 7 (2000) 361-366
12. Kapteijn B.A., Nieweg O.E., Muller S.H., et al. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 38 (1997) 362-366
13. Pijpers R., Collet G.J., Meijer S., et al. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 22 (1995) 1238-1241
14. Mariani G., Gipponi M., Moresco L., et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med 43 (2002) 811-827
15. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
16. Jansen L., Nieweg O.E., Peterse J.L., et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 87 (2000) 484-489
17. Viale G., Mastropasqua M.G., Maiorano E., et al. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 448 (2006) 241-247
18. Cochran A.J. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 23 (1999) 1169-1172
19. Moore R.G., Granai C.O., Gajewski W., et al. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 91 (2003) 378-382
20. Cochran A.J., Balda B.R., Starz H., et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 89 (2000) 236-241
21. Hemminki K., Li X., and Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur J Obstet Gynecol Reprod Biol 101 (2002) 64-69
22. RCOG. Management of vulval cancer; 2006.
23. Homesley H.D., Bundy B.N., Sedlis A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group Study). Am J Obstet Gynecol 164 (1991) 997-1003
24. Burger M.P., Hollema H., Emanuels A.G., et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57 (1995) 327-334
25. Burke T.W., Levenback C., Coleman R.L., et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 57 (1995) 215-220
26. De Hullu J.A., Hollema H., Lolkema S., et al. Vulvar carcinoma. The price of less radical surgery. Cancer 95 (2002) 2331-2338
27. Katz A., Eifel P.J., Jhingran A., et al. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57 (2003) 409-418
28. de Hullu J.A., Ansink A.C., Tymstra T., et al. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynaecol 22 (2001) 199-203
29. Judson P.L., Jonson A.L., Paley P.J., et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol 95 (2004) 226-230
30. De Hullu J.A., Pruim J., Que T.H., et al. Noninvasive detection of inguinofemoral lymph node metastases in squamous cell cancer of the vulva. Int J Gynecol Cancer 9 (1999) 141-146
31. Sohaib S.A., and Moskovic E.C. Imaging in vulval cancer. Best Pract Res Clin Obstet Gynaecol 17 (2003) 543-556
32. Hall T.B., Barton D.P., Trott P.A., et al. The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients. Clin Radiol 58 (2003) 367-371
33. Levenback C., Burke T.W., Gershenson D.M., et al. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 84 (1994) 163-167
34. Decesare S.L., Fiorica J.V., Roberts W.S., et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 66 (1997) 425-428
35. Keshtgar M.R., and Ell P.J. Sentinel lymph node detection and imaging. Eur J Nucl Med 26 (1999) 57-67
36. Ansink A.C., Sie-Go D.M., van der Velden J., et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 86 (1999) 652-656
37. Merisio C., Berretta R., Gualdi M., et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer 15 (2005) 493-497
38. Louis-Sylvestre C., Evangelista E., Leonard F., et al. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 97 (2005) 151-154
39. Boran N., Kayikcioglu F., and Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol 90 (2003) 492-493
40. de Hullu J.A., Oonk M.H., Ansink A.C., et al. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 94 (2004) 10-15
41. Terada K.Y., Shimizu D.M., Jiang C.S., et al. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol 102 (2006) 200-203
42. Martinez-Palones J.M., Perez-Benavente M.A., Gil-Moreno A., et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol 103 (2006) 865-870
43. Radziszewski J, Kowalewska M, Siedlecki J, et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar cancer. In: 15th international meeting of the European society of gynaecological oncology, Berlin, Germany; 2007.
44. Van der Zee A.G., Oonk M.H., De Hullu J.A., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26 (2008) 884-889
45. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics. CA Cancer J Clin 55 (2005) 74-108
46. Benedet J.L., Bender H., Jones III H., et al. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70 (2000) 209-262
47. Beesley V., Janda M., Eakin E., et al. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 109 (2007) 2607-2614
48. Darai E., Lavoue V., Rouzier R., et al. Contribution of the sentinel node procedure to tailoring the radicality of hysterectomy for cervical cancer. Gynecol Oncol 106 (2007) 251-256
49. Schneider A. The sentinel concept in patients with cervical cancer. J Surg Oncol 96 (2007) 337-341
50. Pieterse Q.D., Kenter G.G., Gaarenstroom K.N., et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol 33 (2007) 216-221
51. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 12 (2007) 165-175
52. Boss E.A., Barentsz J.O., Massuger L.F., et al. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 10 (2000) 256-270
53. 18F]-fluoro-2-deoxy-d-glucose-positron emission tomography. Cancer 104 (2005) 2484-2491
54. Sakuragi N., Satoh C., Takeda N., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 (1999) 1547-1554
55. van de Lande J., Torrenga B., Raijmakers P.G., et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol 106 (2007) 604-613
56. Dargent D., Martin X., and Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 79 (2000) 411-415
57. Rob L., Strnad P., Robova H., et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol 98 (2005) 281-288
58. Kushner D.M., Connor J.P., Wilson M.A., et al. Laparoscopic sentinel lymph node mapping for cervix cancer - a detailed evaluation and time analysis. Gynecol Oncol 106 (2007) 507-512
59. Popa I., Plante M., Renaud M.C., et al. Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma. Gynecol Oncol 103 (2006) 649-653
60. Marnitz S., Kohler C., Bongardt S., et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 103 (2006) 35-44
61. Coutant C., Morel O., Delpech Y., et al. Laparoscopic sentinel node biopsy in cervical cancer using a combined detection: 5-years experience. Ann Surg Oncol 14 (2007) 2392-2399
62. Jemal A., Murray T., Ward E., et al. Cancer statistics. CA Cancer J Clin 55 (2005) 10-30
63. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. J Epidemiol Biostat 6 (2001) 47-86
64. Girardi F., Petru E., Heydarfadai M., et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 49 (1993) 177-180
65. Jobo T., Sato R., Arai T., et al. Lymph node pathway in the spread of endometrial carcinoma. Eur J Gynaecol Oncol 26 (2005) 167-169
66. Mariani A., Webb M.J., Keeney G.L., et al. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84 (2002) 437-442
67. Maccauro M., Lucignani G., Aliberti G., et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 32 (2005) 569-574
68. Raspagliesi F., Ditto A., Kusamura S., et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol 191 (2004) 435-439
69. Holub Z., Jabor A., and Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol 23 (2002) 53-57
70. Holub Z., Jabor A., Lukac J., et al. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit 10 (2004) CR587-CR591
71. Barranger E., Cortez A., Grahek D., et al. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol 11 (2004) 344-349
72. Burke T.W., Levenback C., Tornos C., et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 62 (1996) 169-173
73. Lelievre L., Camatte S., Le Frere-belda M.A., et al. Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int J Gynecol Cancer 14 (2004) 271-278
74. Pelosi E., Arena V., Baudino B., et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 24 (2003) 971-975
75. Frumovitz M., Bodurka D.C., Broaddus R.R., et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104 (2007) 100-103
76. Niikura H., Okamura C., Utsunomiya H., et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 92 (2004) 669-674
77. Altgassen C., Pagenstecher J., Hornung D., et al. A new approach to label sentinel nodes in endometrial cancer. Gynecol Oncol 105 (2007) 457-461
78. Cass I., Li A.J., Runowicz C.D., et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol 80 (2001) 56-61
79. Adib T., and Barton D.P. The sentinel lymph node: relevance in gynaecological cancers. Eur J Surg Oncol 32 (2006) 866-874
80. Negishi H., Takeda M., Fujimoto T., et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol 94 (2004) 161-166
81. de Hullu J.A., Hollema H., Piers D.A., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18 (2000) 2811-2816
82. De Cicco C., Sideri M., Bartolomei M., et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 82 (2000) 295-299
83. Levenback C., Coleman R.L., Burke T.W., et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83 (2001) 276-281
84. Puig-Tintore L.M., Ordi J., Vidal-Sicart S., et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 88 (2003) 29-34
85. Hauspy J., Beiner M., Harley I., et al. Sentinel lymph node in vulvar cancer. Cancer 110 (2007) 1015-1023
86. Delaloye J.F., Pampallona S., Chardonnens E., et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol 106 (2007) 89-93